256 related articles for article (PubMed ID: 27819521)
1. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.
Du WZ; Feng Y; Wang XF; Piao XY; Cui YQ; Chen LC; Lei XH; Sun X; Liu X; Wang HB; Li XF; Yang DB; Sun Y; Zhao ZF; Jiang T; Li YL; Jiang CL
CNS Neurosci Ther; 2013 Dec; 19(12):926-36. PubMed ID: 24165291
[TBL] [Abstract][Full Text] [Related]
3. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
4. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
5. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H; Liu Q; Cai T; Chen YD; Wang ZF
Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
[TBL] [Abstract][Full Text] [Related]
6. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
Yang W; Liu Y; Gao R; Yu H; Sun T
Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
9. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
10. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression.
Wang Z; Liu F; Liao W; Yu L; Hu Z; Li M; Xia H
Arch Biochem Biophys; 2020 Aug; 689():108412. PubMed ID: 32445778
[TBL] [Abstract][Full Text] [Related]
12. Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway.
Gong W; Zhao W; Liu G; Shi L; Zhao X
Aging (Albany NY); 2022 Jul; 14(13):5464-5477. PubMed ID: 35802536
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
[TBL] [Abstract][Full Text] [Related]
14. Gli1 is a potential target for alleviating multidrug resistance of gliomas.
Cui D; Xu Q; Wang K; Che X
J Neurol Sci; 2010 Jan; 288(1-2):156-66. PubMed ID: 19818966
[TBL] [Abstract][Full Text] [Related]
15. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
[TBL] [Abstract][Full Text] [Related]
16. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
18. Essential role of Gli proteins in glioblastoma multiforme.
Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S
Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma.
Shang C; Tang W; Pan C; Hu X; Hong Y
Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407
[TBL] [Abstract][Full Text] [Related]
20. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]